Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 74
Filter
1.
Tijdschr Psychiatr ; 60(8): 544-547, 2018.
Article in Dutch | MEDLINE | ID: mdl-30132583

ABSTRACT

It is well known that the use of tranylcypromine in combination with amphetamines may induce a potentially lethal hypertensive crisis. That such a complication may also occur when tranylcypromine is combined with khat, however, is less known. We describe the case of a young patient who received a low dose of tranylcypromine combined with a small amount of khat, subsequently developing a subarachnoid hemorrhage.


Subject(s)
Catha/adverse effects , Drug Interactions , Subarachnoid Hemorrhage/chemically induced , Tranylcypromine/adverse effects , Adult , Drug Combinations , Humans , Male , Tranylcypromine/therapeutic use
2.
J Intellect Disabil Res ; 53(2): 161-8, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19077114

ABSTRACT

BACKGROUND: Persons with profound intellectual and multiple disabilities (PIMD) suffer from a wide range of health problems and use a wide range of different drugs. This study investigated for frequently used medication whether there was a health problem documented in the medical notes for the drug prescribed. METHOD: Persons with PIMD with an estimated intelligence quotient of 25 and profound or severe motor disorders were studied. Data on health problems were taken from medical notes and prescribing data were obtained from pharmacies. Data covering 1 year were analysed. For four therapeutic areas (anticonvulsants, laxatives, drugs for peptic ulcer and gastro-oesophageal reflux disease and psycholeptics), we determined whether we could find an indication for prescribed medication. RESULTS: Some 254 persons with PIMD (46% male, 54% female; median age 49 years, range 6-82) from eight residential facilities participated. Some 226 participants (89%) were prescribed medication over the course of 1 year. An indication for the prescribed medication was documented for 92% (n = 130) (95% confidence interval 88-96%) of 141 participants on anticonvulsants, for 68% (n = 112) (61-75%) of 165 participants on laxatives, for 44% (n = 58) (36-52%) of 132 participants on drugs for peptic ulcer and gastro-oesophageal reflux disease, and for 89% (n = 102) (83-95%) of 115 participants on psycholeptic drugs. CONCLUSIONS: The best level of documentation was found for anticonvulsants the worst for drugs for peptic ulcer and gastro-oesophageal reflux disease. Lack of documenting an indication may be due to off-label use, inadvertent continuation of no longer indicated medication, inadequate documentation and underdiagnosis. Adequate documentation practices are essential because of the communication problems that are characteristic for persons with PIMD.


Subject(s)
Abnormalities, Multiple/drug therapy , Drug Prescriptions/statistics & numerical data , Health Status , Intellectual Disability/drug therapy , Medical Records/statistics & numerical data , Prescription Drugs/therapeutic use , Adolescent , Adult , Aged , Aged, 80 and over , Child , Drug Utilization/statistics & numerical data , Female , Health Surveys , Humans , Male , Middle Aged , Netherlands , Surveys and Questionnaires , Young Adult
3.
Exp Clin Endocrinol Diabetes ; 109(1): 52-5, 2001.
Article in English | MEDLINE | ID: mdl-11573141

ABSTRACT

The uptake of iodide in thyroid epithelial cells is mediated by the sodium/iodide symporter (NIS). The uptake of iodide is of vital importance for thyroid physiology and is a prerequisite for radioiodine therapy in thyroid cancer. Loss of iodide uptake due to diminished expression of the human NIS (hNIS) is frequently observed in metastasized thyroid cancer. So far, no animal model for the study of radioiodine therapy in thyroid cancer has been available. Strategies to restore iodide uptake in thyroid cancer include the exploration of hNIS gene transfer into hNIS defective thyroid cancer. We have performed a stable transfection of hNIS into the hNIS defective follicular thyroid carcinoma cell line FTC133. Stably transfected colonies exhibited high uptake of Na125I, which could be blocked completely with sodium perchlorate. hNIS transfected FTC133 and non-transfected cell lines injected subcutaneously in nude mice formed tumors after 6 weeks. Iodide uptake in the hNIS transfected tumor was much higher than in non-transfected tumor, but a rapid release of radioactivity from the hNIS transfected tumor was observed. Further studies are necessary to investigate the role of hNIS in relation to other thyroid specific proteins in iodide metabolism in thyroid cancer.


Subject(s)
Iodides/metabolism , Symporters/genetics , Thyroid Neoplasms/therapy , Animals , Cell Transplantation , Disease Models, Animal , Genetic Therapy , Humans , Iodine Radioisotopes/metabolism , Iodine Radioisotopes/therapeutic use , Liver/metabolism , Mice , Mice, Nude , Neoplasm Transplantation , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Scintillation Counting , Spleen/metabolism , Symporters/metabolism , Thyroid Neoplasms/metabolism , Time Factors , Transfection
4.
Endocrinology ; 142(9): 3736-41, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11517148

ABSTRACT

Is the fetal thyroid already capable to increase its iodide uptake in response to iodine deficiency? To answer this question, we analyzed the expression of the Na(+)/I(-) symporter and several other genes in the thyroid of rat fetuses at 21 d of gestation from control mothers presenting a mild or more severe iodine deficiency. Female rats were placed on a low iodine diet, not supplemented, or supplemented with iodide or perchlorate for 3 months. The maternal and fetal thyroidal iodide uptake was measured 24 h after injection of 10 microCi Na (125)I into the dams. The absolute iodide uptake of the maternal thyroid was unchanged in a low iodine diet, not supplemented, compared with one supplemented with iodide. In contrast, the fetal thyroid absolute iodide uptake of a low iodine diet, not supplemented, and one supplemented with perchlorate was decreased by 70% and 95% compared with that supplemented with iodide. Na(+)/I(-) symporter mRNA was detected in the fetal thyroid of supplemented with iodide and increased about 2- and 4- fold in the thyroid of fetuses from a low iodine diet, not supplemented, and one supplemented with perchlorate, respectively. Na(+)/I(-) symporter expression was induced in the fetal side of the placenta in both a low iodine diet, not supplemented, and one supplemented with perchlorate; in contrast, Na(+)/I(-) symporter mRNA was never detected in the maternal side of the placenta. Fetal thyroid thyroglobulin and type I deiodinase mRNA contents were only significantly increased with a diet supplemented with perchlorate. Glucose transporter 4 mRNA was decreased in the fetal thyroid of both a low iodine diet, not supplemented, and one supplemented with perchlorate compared with one supplemented with iodide. In conclusion, although the up-regulation of Na(+)/I(-) symporter expression in fetal thyroid and placenta in the low iodine diet, not supplemented group did not lead to restoration of a normal absolute iodide uptake, our data show that all adaptive and/or defending mechanisms against iodine deficiency are already present in the fetus.


Subject(s)
Carrier Proteins/metabolism , Iodine/deficiency , Membrane Proteins/metabolism , Pregnancy Complications/metabolism , Pregnancy, Animal/metabolism , Symporters , Thyroid Gland/embryology , Animals , Carrier Proteins/genetics , Diet , Female , Fetus/metabolism , Iodine/administration & dosage , Iodine/pharmacokinetics , Membrane Proteins/genetics , Placenta/metabolism , Pregnancy , RNA, Messenger/metabolism , Rats , Tissue Distribution , Up-Regulation
5.
Trop Doct ; 31(3): 135-8, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11444330

ABSTRACT

In most African district hospitals there are no separate facilities for psychiatric patients. Aformer general medical officer describes how a ward for these patients was set up at a rural district hospital in Zimbabwe using the already available resources. The effects on the psychiatric care at the hospital and the district are illustrated by two case reports. It is concluded that psychiatric care integrated in primary healthcare, with due regard for the cultural aspects and with cooperation of local healers is feasible, provided that it is supported by additional diagnostic and treatment facilities at the district hospital.


Subject(s)
Hospital Units/organization & administration , Hospitals, District , Mental Disorders/therapy , Mental Health Services/organization & administration , Psychiatric Department, Hospital/organization & administration , Adult , Female , Humans , Rural Health , Zimbabwe
6.
Thyroid ; 10(11): 939-43, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11128720

ABSTRACT

Uptake of iodide is a prerequisite for radioiodine therapy in thyroid cancer. However, loss of iodide uptake is frequently observed in metastasized thyroid cancer, which may be explained by diminished expression of the human sodium iodide symporter (hNIS). Strategies to restore iodide uptake in thyroid cancer include the exploration of hNIS gene transfer into hNIS defective thyroid cancer. In this study, we report the stable transfection of a hNIS expression vector into the hNIS defective follicular thyroid carcinoma cell line FTC133. Stablely transfected colonies exhibited high uptake of Na125I, which could be blocked completely with sodiumperchlorate. hNIS mRNA expression corresponded with iodide uptake in semiquantitative polymerase chain reaction. Iodide uptake was maximal after 60 minutes, whereas iodide efflux was complete after 120 minutes. hNIS transfected FTC133 and control cell lines injected subcutaneously in nude mice formed tumors after 6 weeks. Iodide uptake in the hNIS transfected tumor was much higher than in the nontransfected tumor, which corresponded with hNIS mRNA expression in tumors.


Subject(s)
Carrier Proteins/genetics , Carrier Proteins/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Sodium Iodide/pharmacokinetics , Symporters , Thyroid Neoplasms , Adult , Animals , Disease Models, Animal , Gene Expression Regulation, Neoplastic , Humans , In Vitro Techniques , Iodine Radioisotopes/pharmacokinetics , Male , Mice , Mice, Nude , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Transfection , Tumor Cells, Cultured
7.
Eur J Endocrinol ; 139(4): 448-53, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9820624

ABSTRACT

3,5, 3'-Tri-iodothyronine(T3)is produced by the thyroid and locally, by monodeiodination of thyroxine (T4), in the peripheral tissues. During pregnancy the thyroid hormone status in rats is altered: plasma and tissue levels of T4 and T3 are decreased. We investigated the effects of pregnancy on the contribution of T3 produced locally in the maternal tissues by administering a continuous infusion of [125I]T4 and [131I]T3. The transport of T4 to almost all maternal organs diminished. Less T was transported from the plasma to brown adipose tissue (BAT), liver, kidney and pituitary, in contrast to the ovary where an increase was found. In BAT and brain the amount of locally produced T3 decreased, despite the known increase in deiodinase type II activity in the brain while in liver the contribution of locally produced T3 remained constant, despite a known increase in deiodinase type I activity during pregnancy. This discrepancy between deiodinase activities and locally produced T3 can be explained by an insufficient availability of T4. Thus, we conclude that in the rat a decrease in maternal T4 concentration, together with the transport of T4 to the feto-placental compartment, results indirectly in a diminished availability of T3 in the maternal organs.


Subject(s)
Pregnancy, Animal/metabolism , Thyroxine/metabolism , Triiodothyronine/biosynthesis , Adipose Tissue, Brown/metabolism , Animals , Biological Transport , Brain/metabolism , Female , Iodide Peroxidase/metabolism , Iodine Radioisotopes , Liver/metabolism , Metabolic Clearance Rate , Ovary/metabolism , Pituitary Gland/metabolism , Pregnancy , Rats , Rats, Wistar
8.
Eur J Endocrinol ; 138(6): 713-8, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9678542

ABSTRACT

During pregnancy maternal thyroid hormones are of great importance for normal development of the central nervous system of the fetus. Iodine deficiency of the mother carl result in an impaired development of the fetal brain. In large areas of the world iodine intake is moderately low. To study the effects of marginal iodine deficiency (MID) on the production, distribution, and transport of thyroxine (T4) and 3,5,3'-tri-iodothyronine (T3) in nonpregnant and near-term pregnant rats we performed kinetic experiments (three-compartment analysis). Despite unchanged plasma T4 and T3 during MID, the production and plasma clearance rates of T4 decreased 30% (P = 0.01) in MID nonpregnant (MID-C) rats. For T3, the plasma clearance rate was increased 70% (P = 0.046), while the T3 production was more than doubled (P = 0.042) in MID-C rats. In MID near-term pregnant rats T3 production was decreased 20% (P = 0.04). Hepatic deiodinase type I activity increased during MID in both nonpregnant and pregnant rats. It appears that during MID, rats are able to maintain their euthyroid status. The pronounced increase in transport of T4 from plasma to the fast pool observed in pregnant rats on a normal iodine diet did not occur during MID. In conclusion, in rats MID affects maternal thyroid hormone metabolism, thus influencing the availability of maternal T4 for the fetus.


Subject(s)
Iodine/deficiency , Maternal-Fetal Exchange , Pregnancy, Animal/metabolism , Thyroxine/biosynthesis , Triiodothyronine/biosynthesis , Animals , Biological Transport/physiology , Body Weight/physiology , Female , Hormones/blood , Iodine/urine , Metabolic Clearance Rate , Placental Function Tests , Pregnancy , Rats , Rats, Wistar , Thyroxine/metabolism , Tissue Distribution , Triiodothyronine/metabolism
9.
Endocrinology ; 139(5): 2229-34, 1998 May.
Article in English | MEDLINE | ID: mdl-9564827

ABSTRACT

Iodothyronine deiodinases, types I, II, and III (D1, D2, and D3) activities were measured in tissues of fetal rats, at 18 and 21 days of gestation, at several levels of iodine deficiency (ID): mild ID diet (MID) and moderately severe ID, MID + 0.005% perchlorate (MID+P). D2 was present in fetal skin, increased between days 18 and 21, and also in MID and MID+P. In skin, D3 increased during ID at day 18, whereas there was a decrease at day 21. Skin T4 decreased in MID and MID+P, showing an inverse relationship with D2. Skin T3 decreased at day 18 in MID and MID+P but increased at day 21, probably because of the increased D2 and decreased D3, maintaining T3 concentrations. No effect of ID was observed on hepatic D1. D2 increased in brain and brown adipose tissue at day 21 in MID+P. No changes were found in maternal placental D2 and D3, but D2 and D3 increased in the fetal placenta at day 18 in MID+P. A higher level of D2 is present in fetal skin than in the brain. As the activity is increased, in even mild ID (and already at 18 days) it can be concluded that skin D2 is likely to be of considerable physiological importance, at least for fetal thyroid hormone economy, by contributing to the intracellular T3 content of the skin and, possibly, to the plasma T3.


Subject(s)
Fetus/enzymology , Iodide Peroxidase/metabolism , Iodine/deficiency , Skin/embryology , Skin/enzymology , Triiodothyronine/metabolism , Adipose Tissue, Brown/embryology , Adipose Tissue, Brown/enzymology , Animals , Brain/embryology , Brain/enzymology , Female , Gestational Age , Isoenzymes/metabolism , Liver/embryology , Liver/enzymology , Placenta/enzymology , Pregnancy , Rats , Thyrotropin/blood , Thyroxine/metabolism
10.
Am J Physiol ; 274(2): E253-6, 1998 02.
Article in English | MEDLINE | ID: mdl-9486155

ABSTRACT

The synthetic flavonoid EMD-49209 is a potent inhibitor of the in vivo and in vitro binding of thyroxine (T4) to transthyretin (TTR). We studied the distribution of 125I-labeled EMD-49209 in maternal tissues, intestinal contents, and fetal tissues in rats that were 20 days pregnant (from 1 to 24 h after intravenous injection). The percent dose of EMD decreased quickly with time. In maternal brain no radioactive flavonoid could be detected. EMD was excreted very rapidly from the intestines. In the fetal compartment the percent dose of EMD increased with time; after 24 h it contained 17% of the EMD. The flavonoid was found in all fetal tissues investigated and also in the fetal brain. Because TTR concentrations are high in the fetal rat, especially in the brain, the transfer of flavonoid to the fetal brain might be linked to TTR expression. The presence of flavonoid in the fetal brain raises the possibility of an essential interference of flavonoids with the availability of T4 in the fetal compartment.


Subject(s)
Blood-Brain Barrier , Brain/embryology , Enzyme Inhibitors/pharmacokinetics , Flavonoids/pharmacokinetics , Placenta/metabolism , Animals , Female , Iodide Peroxidase/antagonists & inhibitors , Maternal-Fetal Exchange , Pregnancy , Rats , Rats, Wistar , Tissue Distribution
11.
Eur J Endocrinol ; 138(1): 113-9, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9461326

ABSTRACT

Thyroid hormones are extremely important for development of the fetal central nervous system. Thyroidectomy results in severe hypothyroidism. In this study two levels of maternal hypothyroidism were reached by administration of different amounts of thyroxine (T4) and 3,5,3'-tri-iodothyronine (T3) to thyroidectomized pregnant rats. We examined the production, distribution and transport of T4 and T3 by performing a kinetic experiment (three-compartment analysis) with intact and thyroidectomized near-term pregnant rats which received either very low (Tx + lowTH) or normal (Tx + TH) doses of T4 and T3. Despite administration of normal doses of thyroid hormones, plasma TSH was still elevated in the Tx + TH rats, meaning that these rats were still mildly hypothyroid. The Tx + lowTH rats were markedly hypothyroid, the plasma T4 and T3 levels being very low. In the mildly hypothyroid rats the transport of T4 from plasma to the fast pool and vice versa was decreased compared with intact near-term pregnant rats. This could imply that much less T4 is transported to the feto-placental compartment. Liver type I deiodinase was decreased, resulting in lowered plasma T3 values. In the markedly hypothyroid rats all pools and rates of transport of T4 and T3 were greatly decreased. In conclusion, even mild hypothyroidism, despite normal plasma T4 values, results in significant changes, especially in maternal T4 transport. We suggest that even mild maternal hypothyroidism will have a negative effect on the availability of maternal T4 for fetuses.


Subject(s)
Hypothyroidism/blood , Pregnancy Complications/blood , Pregnancy, Animal/blood , Thyroxine/blood , Triiodothyronine/blood , Animals , Body Weight , Female , Gestational Age , Glycerolphosphate Dehydrogenase/metabolism , Hypothyroidism/enzymology , Hypothyroidism/pathology , Iodide Peroxidase/metabolism , Isoenzymes/metabolism , Kinetics , Liver/enzymology , Pregnancy , Pregnancy, Animal/metabolism , Rats , Rats, Wistar
12.
Am J Physiol ; 272(6 Pt 1): E997-1001, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9227443

ABSTRACT

The hypothesis that propionate is a short-term feed intake-regulating agent was studied. Mature wether sheep were infused over 20 min with Na propionate into the mesenteric vein, while feed intake and feeding pattern were monitored over 1.5 h. Feed intake was reduced by infusions at 2 mmol/min, which were associated with marked increases in jugular as well as portal concentrations of insulin, glucose, and propionate. In a second experiment, animals were infused with 2 mmol/min Na propionate into the portal vein. No decrease in feed intake was observed, although there were similar increases in insulin, glucose, and propionate as found in mesenteric vein-infused animals. It is concluded that mesenteric propionate in high doses acts as a satiety factor. Possible explanations for the difference between site of infusion may be a different distribution of the infusate over the liver and/or the presence of propionate-sensitive receptors in the mesenteric/portal vein region. It seems unlikely that insulin concentrations are involved in inducing satiety in propionate-infused animals.


Subject(s)
Blood Glucose/metabolism , Feeding Behavior/drug effects , Insulin/metabolism , Propionates/pharmacology , Animals , Female , Infusions, Intravenous , Insulin/blood , Insulin Secretion , Jugular Veins , Male , Mesenteric Veins , Orchiectomy , Portal Vein , Propionates/administration & dosage , Propionates/pharmacokinetics , Sheep , Time Factors
13.
Eur J Endocrinol ; 136(3): 324-9, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9100559

ABSTRACT

Treatment of rats with phenytoin (DPH), an anti-epileptic drug, results in lower tissue thyroid hormone (TH) levels and interferes with the metabolic pathway of TH. To test the hypothesis that DPH affects the enterohepatic cycle of TH and, thus, the kinetics of TH turnover, we performed a kinetic experiment (three-compartment analysis) and a steady-state, double-isotope equilibrium experiment in rats treated for 3 weeks with DPH (50 mg/kg body weight per day) and in untreated controls. This included measurements of TH and TH metabolite levels, as well as the activities of enzymes involved in the TH metabolic pathway. DPH treatment resulted in a decrease in the production of thyroxine (T4) (by 25%) and tri-iodothyronine (T3) (by 37%), a decrease in the T3 concentration in all three pools, and a redistribution of T4 from the fast to the slow pool. The amount of T4 increased in intestinal contents and feces by 66% and 71% respectively. Expressed as a fraction of daily TH disposal, fecal loss of T4 was enhanced from 10 to 23% and that of T3 from 16 to 21%. An increase in T4 and T3 UDP-glucuronyltransferase activities was observed, suggesting that the increased fecal loss of T4 and T3 is secondary to an increased biliary output of their glucuronides. The reduced secretion of TH and increased fecal clearance during DPH treatment can lead in the long run to depletion of TH stores.


Subject(s)
Phenytoin/pharmacology , Thyroxine/metabolism , Triiodothyronine/metabolism , Animals , Feces/chemistry , Intestinal Mucosa/metabolism , Kinetics , Male , Rats , Rats, Wistar , Thyroxine/analysis , Triiodothyronine/analysis
14.
Endocrinology ; 138(1): 79-84, 1997 Jan.
Article in English | MEDLINE | ID: mdl-8977388

ABSTRACT

The synthetic flavonoids EMD 23188 and EMD 49209, developed as T4 analogs, displace T4 from transthyretin, and in vitro they inhibit 5'-deiodinase activity. In vivo EMD 21388 causes tissue-specific changes in thyroid hormone metabolism. In tissues that are dependent on T3 locally produced from T4, total T3 was diminished. It was not known whether it was the presence of EMD interfering with 5'-deiodinase type II in tissues or the decreased T4 (substrate) availability that caused the lowered T3. To study whether the flavonoids enter tissues and, if this were the case, whether they enter tissues similarly, [125I]EMD 49209 together with [131I]T4 were injected into female rats and rats pretreated with EMD 21388. Tissues were extracted and submitted to HPLC. [125I]EMD 49209 disappeared quickly from plasma and enters peripheral tissues; peak values were reached after 0.25-0.5 h. Then [125I]EMD 49209 appeared in the intestines (after 6 h 40% of the dose). Tissue uptake of [131I]T4 was very rapid. EMD 21388 pretreatment caused an increase in the excretion of [125I]EMD 49209 into the intestines (40% after 0.25 h). The uptake of [131I]T4 increased, but not high enough to ensure normal tissue T4 concentrations. In the 5'-deiodinase type II-expressing tissues, no [125I]EMD 49209 could be detected. We conclude that the decrease in T3 locally produced from T4 is caused by the shortage of T4 as substrate and not to a direct effect of EMD on the activity of 5'-deiodinases I and II.


Subject(s)
Enzyme Inhibitors/pharmacokinetics , Flavonoids/pharmacology , Iodide Peroxidase/antagonists & inhibitors , Thyroxine/pharmacokinetics , Animals , Female , Flavonoids/pharmacokinetics , Rats , Rats, Wistar , Tissue Distribution
15.
Am J Physiol ; 273(6): E1121-6, 1997 12.
Article in English | MEDLINE | ID: mdl-9435527

ABSTRACT

Iodide uptake by the thyroid is an active process. Iodine deficiency and pregnancy are known to influence thyroid hormone metabolism. The aim of this study was to clarify the effects of iodine deficiency and pregnancy on iodide uptake by the thyroid. Radioiodide was injected intravenously into nonpregnant and 19-day pregnant rats receiving a normal or marginally iodine-deficient diet. The uptake of radioiodide by the thyroid was measured continuously for 4 h. The absolute iodide uptake by the maternal and fetal thyroid glands at 24 h was calculated by means of the urinary specific activity. Pregnancy resulted in a decrease in the absolute thyroidal iodide uptake. Marginal iodine deficiency had no effect on the absolute iodide uptake by the maternal thyroid. The decreased plasma inorganic iodide was compensated by an increase in thyroidal clearance. A similar compensation was not found for the fetus; the uptake of iodide by the fetal thyroid decreased by 50% during marginal iodine deficiency. This can lead to diminished thyroid hormone production, which will have a negative effect on fetal development, especially of the brain.


Subject(s)
Iodides/pharmacokinetics , Iodine/deficiency , Pregnancy Complications/metabolism , Thyroid Gland/physiology , Animals , Biological Transport , Body Weight , Feeding Behavior , Female , Iodides/urine , Iodine Radioisotopes/pharmacokinetics , Litter Size , Models, Biological , Pregnancy , Rats , Rats, Wistar , Thyroid Gland/embryology , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood
16.
Eur J Endocrinol ; 134(2): 221-4, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8630523

ABSTRACT

Treatment of rats with phenytoin (DPH), an anti-epileptic drug, results in lower tissue thyroid hormone (TH) levels. To investigate if this is accompanied by tissue hypothyroidism, rats were treated for 3 weeks with DPH (50 mg/kg body wt in food). Thyroid hormone-dependent parameters were measured, and the results were compared to those of control rats and to those of athyreotic rats substituted with thyroxine + triiodothyronine (Tx + TH) to reach the same plasma TH levels as DPH-treated rats. These rats were mildly hypothyroid with regard to their TH and TSH levels and TH-dependent parameters. Both DPH and Tx + TH led to a decrease in plasma thyroxine (T4) and triiodothyronine (T3) (+/-70% of the control). The percentage free T4 was unchanged. Plasma thyrotropin (TSH) was increased only in the Tx + TH rats (sixfold). For DPH rats, pituitary hormone content was not different from the control; growth hormone was lower and TSH was higher in Tx + TH rats. In DPH and Tx + TH rats, an increase in hepatic T4 and T3 uridine-diphosphate glucuronyltransferase activity was found, likewise indicating a change in the metabolic pathway of TH. Hepatic iodothyronine deiodinase (ID) type I activity decreased in Tx + TH rats but did not alter in DPH rats. Hepatic alpha-glycerophosphate dehydrogenase (alpha-GPD) decreased in DPH and Tx + TH rats. Malic enzyme in liver was enhanced in DPH rats. In the brains of DPH rats the level of alpha-GPD activity was raised; in Tx + TH it was lowered. The ID type II activity in the brain was reduced in DPH rats, but ID type III did not change for either group. Total body oxygen consumption increased in DPH rats (13%); it decreased in Tx + TH rats (9%). Our results show that DPH causes changes comparable to mild hypothyroidism. The lack of or a diminished hypothyroid response can be explained as the attenuating agonistic effect of DPH, which is supported by O2 consumption, brain ID type II and alpha-GPD activities. The T4 content was reduced by 30% in thyroid digests; this, together with a reduced T4 secretion, can lead to serious hypothyroxinemia during prolonged DPH treatment.


Subject(s)
Anticonvulsants/pharmacology , Phenytoin/pharmacology , Thyroid Gland/drug effects , Thyroid Gland/physiology , Animals , Growth Hormone/metabolism , Liver/drug effects , Liver/metabolism , Male , Oxygen Consumption , Pituitary Gland/metabolism , Rats , Rats, Wistar , Thyrotropin/metabolism , Thyroxine/metabolism , Thyroxine/pharmacology , Triiodothyronine/metabolism , Triiodothyronine/pharmacology
17.
J Endocrinol ; 146(1): 87-94, 1995 Jul.
Article in English | MEDLINE | ID: mdl-7561625

ABSTRACT

The pituitary-ovarian axis was studied after withdrawal of thyroid hormone in 131I-radiothyroidectomized adult female rats. Oestrous cycles became prolonged and irregular within 2 weeks after the supply of thyroid hormone was stopped. If an LH surge occurred in hypothyroid rats on the day of vaginal pro-oestrus it was significantly greater in rats which had been made hypothyroid for 4-5 weeks than in controls; in hypothyroid rats with an LH surge on pro-oestrus, plasma progesterone showed a rise similar to that in controls at pro-oestrus; the ovulation rate was decreased in hypothyroid rats. About half of the rats from which blood was sampled daily in the afternoon between 7 and 18 days after tri-iodothyronine (T3) withdrawal had 1 day of pro-oestrus; on this day the LH surge was higher than in controls. On days 2 and 1 before and days 1 and 2 after this pro-oestrus, plasma progesterone was similar to that of controls on days 2 and 1 before and days 1 and 2 after pro-oestrus respectively. However, progesterone was higher in the period before and after these days. The other hypothyroid rats showed no pro-oestrus and no LH surge during this period, while their plasma progesterone levels were high on all days. On the morning of day 10 after T3 withdrawal and 5 days after the preceding pro-oestrus, most hypothyroid rats had high progesterone and low oestradiol plasma levels.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Hypothyroidism/physiopathology , Ovary/physiopathology , Pituitary Gland/physiopathology , Proestrus , Animals , Estradiol/blood , Female , Gonadotropin-Releasing Hormone/pharmacology , Hypothyroidism/blood , Luteinizing Hormone/blood , Ovulation/drug effects , Progesterone/blood , Rats , Rats, Wistar , Time Factors
18.
Am J Clin Nutr ; 61(6): 1257-62, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7762527

ABSTRACT

Iodine excretion in urine after oral dosing with iodized oil is influenced by various factors involved in the retention and elimination of iodine by the body. In a study comparing different treatments of severely iodine-deficient schoolchildren from Malawi, a hyperbolic function was found to describe changes in urinary iodine concentration over time more adequately than a simple exponential function. Compared with oil A, comprising ethyl esters of iodized fatty acids, the retention and elimination of iodine from oil B, comprising triacylglycerol esters of iodized fatty acids, were significantly greater. The mean duration of effectiveness of oral iodized oil, based on urinary iodine concentrations > 0.40 mumol/L, was estimated to be 13.7, 9.9, and 52.5 wk for a single dose of iodized oil A (490 mg I), a split dose of iodized oil A (2 x 245 mg I), and a single dose of iodized oil B (675 mg I), respectively. Dividing the dose of oil A into two equal amounts given on consecutive days did not improve its efficacy.


Subject(s)
Iodine/urine , Iodized Oil/administration & dosage , Administration, Oral , Child , Female , Humans , Iodine/deficiency , Iodized Oil/metabolism , Male , Models, Biological , Time Factors
19.
Poult Sci ; 74(3): 523-37, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7761338

ABSTRACT

The theory that net muscle growth is, at least partly, regulated by catabolic factors has been tested in order to set up an animal model to study meat aging and post-mortem tenderization. Male and female chickens of a layer strain (White Leghorn), a commercial broiler strain (Ross), and two experimental broiler lines (designated GL and FC) were used to estimate differences in proteolytic enzyme activities in the breast muscles. The GL and the FC lines were selected for high body weight gain and high feed efficiency, respectively. At 6 wk of age the birds were slaughtered and the activities of endogenous proteinases and their specific inhibitors in breast muscles measured. The Leghorns showed significant differences in all traits compared with the three broiler genotypes. Within the broiler types, FC birds tended in the direction of the Leghorns and GL birds in the opposite direction. Ross birds were intermediate between FC and GL birds. All types and sexes differed significantly in slaughtering weight. Feed conversion ratio and protein conversion ratio were highest for Leghorns. The FC birds showed the lowest feed conversion. Ross and GL birds showed intermediate values. The Leghorns showed higher calpain activities and lower calpastatin activity than the three broiler genotypes. The FC broilers showed intermediate calpain and calpastatin activities but higher cathepsin H and total cystatin values. The GL broilers showed lower cathepsin B, D, and H activities. In all cases the Ross broilers showed intermediate values. From these figures it is concluded that the strains of birds used in this study can be used as a natural source of variability to study the mechanisms involved in post-mortem proteolytic degradation and thus in the study of muscle tenderization and meat aging. It is also concluded that it could be very interesting to study the behavior of the different proteolytic systems more carefully in relation to muscular growth characteristics and compare them to anabolic factors involved in muscle growth.


Subject(s)
Body Weight , Calcium-Binding Proteins/metabolism , Calpain/metabolism , Cathepsins/metabolism , Chickens/metabolism , Muscle, Skeletal/enzymology , Animals , Chickens/growth & development , Female , Male , Sex Factors , Species Specificity
20.
J Endocrinol Invest ; 18(3): 214-9, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7615907

ABSTRACT

In man, GHRH has been shown to potentiate the TSH-releasing activity of TRH. To study the way by which GHRH affects TRH-stimulated TSH release, we examined the effect of GHRH (1-29)NH2 on basal and stimulated TSH secretion in intact male rats and superfused dispersed rat pituitary cells. In the intact rats, GHRH(1-29)NH2 potentiated TRH-stimulated TSH release in the evening, but potentiation was not observed in the morning and in dispersed pituitary cells. Basal TSH levels were not changed by GHRH(1-29)NH2. It is concluded that GHRH(1-29)NH2 potentiates the TSH-releasing activity of TRH in the evening in rats possibly through suprahypophyseal disinhibition.


Subject(s)
Growth Hormone-Releasing Hormone/pharmacology , Thyrotropin/metabolism , Animals , Drug Synergism , Kinetics , Male , Pituitary Gland, Anterior/drug effects , Pituitary Gland, Anterior/metabolism , Rats , Rats, Wistar , Thyrotropin-Releasing Hormone/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...